This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

PBM Contracting Summit
December 9-10, 2025
Pre-Summit Workshop on December 8thIntercontinental Chicago Magnificent Mile | Chicago, IL

Steve Boyd
EVP, Business Development, Owner and Cofounder at Liviniti
Speaker

Profile

Steven T. Boyd is widely recognized as a thought leader and driving force in the pharmacy industry, dedicated to increasing value, promoting optimal performance, and building strong customer and client relationships. Drawing from two decades as a clinical pharmacist within academia, independent pharmacy and managed care, Steve’s comprehensive background serves as a strong foundation for solving pharmacy benefits challenges and combating rising specialty drug costs.
Previously, Steve gained significant experience as the owner and operator of two pharmacies focused on retail and specialty packaging. In the academic arena, he was promoted to Associate Professor, awarded grants nearing $1M of public funding,
co-authored a popular pharmacy board review book, and served as primary author of
20+ peer-reviewed pharmacy manuscripts.
A licensed pharmacist in 17 states, Steve has been honored to be named the Louisiana Pharmacy Association’s 2006 Distinguished Young Pharmacist of the Year and 2011 Pharmacist of the Year.
Steve earned his PharmD at the University of Nebraska Medical Center and completed a primary care residency at the University of Mississippi Medical Center. He resides in Natchitoches, LA with his wife LeAnn, the Chief Executive Officer of Liviniti. They are proud parents of three children, Landon, Lilly Ann and Lacey.











Agenda Sessions

  • GLP-1 Cost, Coverage, and Care - Continuum or Conundrum?

    3:30pm
  • Alternative Funding Programs — Perspectives on Risk, Compliance, and Cost in Managing High-Cost Therapies

    3:45pm